Mette Munk Lauridsen: Clinical Trials

1 trial sponsored by Mette Munk Lauridsen, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable1Completed 1

Follow Mette Munk Lauridsen: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Diagnosis of Covert/Minimal Hepatic Encephalopathy by Means of Continuous Reaction Time Measurement
Lactulose and rifaximin, Branched Chain amino acids, Placebo - Liver Cirrhosis, Hepatic Encephalopathy
Not applicableCompletedMette Munk Lauridsen1362013-01-012016-02-23

Conditions studied

Hepatic Encephalopathy (1)  ·  Liver Cirrhosis (1)

Interventions

Amino Acids (1)  ·  Lactulose (1)  ·  Rifaximin (1)

Countries

Denmark (1)

Top investigators

Hendrik Vilstrup, Professor (1)  ·  Jeppe Gram, PhD, MD (1)  ·  Ove Schaffalitzky de Muckadell, Professor (1)